Duvadilan Retard Capsule (Isoxsuprine HCl 40 mg SR)

Last Updated on 11/06/2026 ✔ Medically Reviewed by Dr. Arjun Srivastav

Clinical Summary: Duvadilan Retard Capsule is an oral sustained-release (SR) tocolytic and peripheral vasodilator manufactured by Abbott. Each capsule delivers 40 mg of Isoxsuprine Hydrochloride formulated for extended release. Prescribed in obstetrics and vascular medicine, Duvadilan Retard is clinically indicated for the arrest and prevention of premature labour, the management of threatened miscarriage, and the treatment of peripheral vascular circulatory disorders (including Raynaud’s phenomenon and Buerger’s disease). By stimulating beta-2 adrenergic receptors, it relaxes uterine smooth muscle and dilates peripheral blood vessels without the sharp cardiovascular fluctuations of immediate-release tablets.

Product Specifications

What is Duvadilan Retard Capsule?

A duvadilan retard capsule is an extended-release formulation designed to solve a historical challenge with isoxsuprine therapy.

Immediate-release isoxsuprine tablets are absorbed rapidly, producing sharp concentration spikes in maternal blood that frequently cause distressing heart palpitations, tremors, and sudden drops in blood pressure. The “Retard” formulation uses micro-pellets that release the active medicine gradually over several hours. This sustained-release action keeps uterine contractions suppressed throughout the day and night while minimizing cardiovascular side effects.

What is Duvadilan Retard Capsule Used For?

Clinicians prescribe Duvadilan Retard Capsule across two distinct medical specialties:

1. Obstetrics: Uterine Relaxation & Preterm Labour Prevention

• Arresting Unscheduled Premature Labour: Used in pregnant women (typically between 20 and 36 weeks of gestation) showing early signs of premature labour, such as regular, painful uterine contractions or premature cervical effacement.
• Management of Threatened Miscarriage: In the late first and second trimesters, hyperactive uterine contractions can compromise placental attachment. Duvadilan Retard calms the myometrium to support pregnancy continuation.
• Gaining Critical Clinical Time: In acute threatened labour, relaxing the uterus buys a vital 24- to 48-hour window for maternal antenatal corticosteroid injections (which accelerate fetal lung surfactant production) and allows safe transport to a specialist neonatal medical centre.
• Relief of Severe Dysmenorrhea: Relaxes hypertonic uterine muscle spasms, providing relief from severe menstrual cramping.

2. Vascular Medicine: Peripheral Circulation Support

• Raynaud’s Phenomenon & Disease: Helps relieve painful, cold-induced vasospasms in the fingers and toes by dilating constricted digital arterioles.
• Arteriosclerosis Obliterans: Enhances microvascular perfusion to the lower extremities in patients suffering from arterial narrowing and claudication.
• Thromboangiitis Obliterans (Buerger’s Disease): Improves collateral capillary blood flow in inflamed, narrowed peripheral vessels of the hands and feet.
• Cerebrovascular Insufficiency: Used as supportive therapy to improve microcirculatory blood flow to cerebral capillary beds.

How It Works: Mechanism of Action

Isoxsuprine acts primarily as a beta-adrenergic receptor agonist with direct action on vascular and myometrial smooth muscle:

1. Uterine Relaxation: Isoxsuprine binds to -adrenergic receptors on myometrial cells, activating the enzyme adenylate cyclase. This increases cyclic adenosine monophosphate (cAMP) levels, which drives calcium out of the cell cytoplasm and inactivates myosin light-chain kinase. Without free calcium, muscle filaments cannot contract, causing the uterus to relax and halting contractions.
2. Peripheral Vasodilation: The same  agonism relaxes arterial walls, particularly in the deep vasculature of skeletal muscle, easing vascular resistance and improving blood circulation to cold or ischemic limbs.

Dosage & Administration Protocols

Because Duvadilan Retard uses a sustained-release mechanism, strict adherence to ingestion guidelines is essential:

Safety Precautions & Maternal Red Flags

Pregnant women taking a duvadilan retard capsule should be aware of expected physiological reactions versus symptoms requiring urgent medical review:

Expected, Manageable Reactions

• Mild Maternal Heart Rate Increase: Because  agonists produce a minor crossover stimulation of  cardiac receptors and cause peripheral vasodilation, maternal pulse rate may increase by 10 to 15 beats per minute.
• Mild Postural Lightheadedness: Dilated blood vessels can temporarily lower blood pressure. Stand up slowly from beds and chairs to allow your cardiovascular system to adapt.

Urgent Warning Signs: Seek Immediate Medical Care

• Breaking of Waters (Rupture of Membranes): If you notice a sudden trickle or gush of fluid from your vagina, contact your delivery unit immediately.
• Vaginal Bleeding: Any fresh, bright-red vaginal spotting or bleeding requires urgent evaluation to rule out placental complications.
• Shortness of Breath or Chest Tightness: High-dose -agonists in pregnancy can rarely lead to fluid retention in the lungs (pulmonary edema). Contact your doctor immediately if you experience breathing difficulties or persistent chest pain.
• Contractions Becoming More Frequent: If painful uterine tightenings increase in frequency (e.g., more than 4 contractions in an hour), go directly to the hospital.

Absolute Contraindications & Drug-Drug Interactions

Duvadilan Retard must NOT be used under the following clinical conditions:

Absolute Obstetrical Contraindications

• Intra-amniotic Infection (Chorioamnionitis): Delaying delivery in the presence of uterine infection places mother and baby at risk of severe sepsis.
• Placental Abruption or Severe Hemorrhage: Concealed or active uterine bleeding requires obstetric intervention, not tocolysis.
• Severe Pre-eclampsia or Eclampsia: High maternal blood pressure and proteinuria require clinical management and potential delivery.
• Intrauterine Fetal Death or Lethal Fetal Anomaly: Tocolysis is clinically contraindicated.
• Immediately Postpartum: Must never be administered right after birth, as relaxed uterine muscles can cause severe postpartum hemorrhage.

Absolute Medical & Cardiovascular Contraindications

• Maternal cardiac arrhythmias, severe tachycardia, or ischemic heart disease.
• Uncontrolled maternal hyperthyroidism (thyrotoxicosis).

Significant Drug Interactions

• Other Antihypertensives & Vasodilators: Combining Duvadilan Retard with other blood-pressure-lowering drugs produces additive hypotensive effects.
• Other Beta-Agonists: Concurrent use with medicines like salbutamol or terbutaline significantly increases the risk of maternal tachycardia and arrhythmias.

Side Effect Profile

Adverse reactions reflect the drug’s vasodilatory and adrenergic actions:

Where Can I Buy Duvadilan Retard Capsule?

You can order authentic Duvadilan Retard directly from AustraliaRxMeds:

• Direct Online Ordering: Purchase securely via Buy Duvadilan Retard Capsule Online at Australiarxmeds in factory-sealed, tamper-evident blister packaging.
• Packaging & Delivery Details: Supplied in blister strips of 15 sustained-release capsules with tracked international shipping and protective packaging to safeguard product stability.
• Australian Regulatory & Importation Compliance: In Australia, isoxsuprine is a Schedule 4 (S4 / Prescription Only) medication. Australian residents can legally import this medicine under the Therapeutic Goods Administration (TGA) Personal Importation Scheme, which requires:
  • A valid prescription written by an Australian-registered medical practitioner or obstetrician.
  • Importing no more than a 3-month supply per single shipment at the doctor’s prescribed dose.
  • Ensuring total imported volume across a 12-month period does not exceed a 15-month supply.
  • The medication must be strictly for personal therapeutic use.
• Authenticity Assurance: Ordering through AustraliaRxMeds ensures you receive genuine, regulated pharmaceutical products manufactured under certified Good Manufacturing Practice (GMP) standards.

Medical References

1. Abbott India Ltd. Duvadilan Retard (Isoxsuprine Hydrochloride 40 mg Sustained-Release Capsules): Prescribing Information and Clinical Monograph.
2. Therapeutic Goods Administration (TGA).Poisons Standard: Schedule 4 – Isoxsuprine Hydrochloride. Australian Government Department of Health and Aged Care.
3. World Health Organization (WHO). WHO Recommendations on Interventions to Improve Preterm Birth Outcomes: Tocolytic Therapy in Established Preterm Labour.
4. Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Management of Preterm Labour Clinical Practice Guidelines.
5. American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin No. 171: Management of Preterm Labor. Obstetrics & Gynecology.
6. Medina-Ruiz, D., et al. (2019). Vasodilation Elicited by Isoxsuprine: Activation of NO/cGMP and Calcium Channel Modulation in Vascular Beds. PMC6429095.